
Cardiac Anesthesia Case Optimization
Generate optimized anesthetic plans for complex cardiac surgeries with risk stratification
What You Can Do
You receive Claude-generated anesthetic plans that systematically address preoperative risk stratification, induction drug selection, hemodynamic management protocols, and real-time problem-solving for complex cardiac surgeries. Claude synthesizes patient comorbidities, surgical complexity, and current cardiac physiology evidence into actionable clinical decisions, accelerating the hours-long planning process while supporting your independent clinical judgment.
Features
analyzes ejection fraction, pulmonary hypertension, renal function, and comorbidities to classify perioperative risk
identifies contraindications and synergistic effects across ACE inhibitors, beta-blockers, anticoagulants, and inotropes
recommends specific agents and dosing when standard approaches are contraindicated (hemodynamic instability, difficult airway)
outlines target blood pressures, vasopressor/inotrope selection, and fluid management for each surgical phase
specifies TEE, arterial line, CVP, or PAC requirements based on case complexity and pathology
pre-identifies likely intraoperative challenges (arrhythmias, myocardial ischemia, pulmonary hypertensive crisis) with mitigation strategies
tailors volatile/total IV anesthesia choice, opioid dosing, and muscle relaxant selection to cardiac physiology
Example Output
Case: 68M with EF 28%, severe MR, on carvedilol/lisinopril, elective CABG
Risk Assessment:
- Moderate-high perioperative risk (EF <35%, age >65, polypharmacy)
- Ejection fraction limits sympathomimetic tolerance
- Carvedilol continuation reduces intraoperative tachycardia/hypertension risk
Induction Strategy:
- Etomidate 0.1-0.15 mg/kg (preserves SVR) + remifentanil 1-2 mcg/kg over 90 seconds
- Avoid propofol (excessive afterload reduction with depressed EF)
- Phenylephrine boluses standby for induction hypotension
Hemodynamic Targets:
- MAP 60-75 mmHg intraop (avoid excessive BP swings)
- Maintain HR 50-70 (beta-blockade benefit)
- SVR 800-1200 dynes·s·cm⁻⁵
- Prepare milrinone 0.3-0.5 mcg/kg/min if CO drops post-bypass
Monitoring:
- Radial arterial line (beat-to-beat pressure for high-risk patient)
- TEE mandatory (assess MR severity, wall motion, SVC/IVC filling)
- CVP line (volume responsiveness assessment)
Anticipated Issues & Mitigation:
- Acute decompensation on CPB: Have inhaled pulmonary vasodilators ready; reduce bypass flow to prevent distension
- Arrhythmias post-bypass: Avoid hypokalemia; consider amiodarone prophylaxis
What's Included
- SKILL.md: complete skill framework and clinical decision logic
- Cardiac Risk Stratification Checklist: systematic patient assessment template (EF, arrhythmias, comorbidities, medications)
- Induction Strategy Decision Tree: drug selection flowchart for hemodynamically compromised patients
- Hemodynamic Management Protocol Template: target ranges and drug dosing by surgical phase (induction, bypass, emergence)
- Drug Interaction Matrix: preoperative medication review checklist for cardiac cases (beta-blockers, ACE-I, anticoagulants, antiarrhythmics)
Who It's For
- Anesthesiologists managing complex cardiac cases requiring systematic preoperative planning and risk mitigation
- CRNAs (Certified Registered Nurse Anesthetists) in cardiac surgical centers needing evidence-based protocol development
- Cardiac anesthesia fellows accelerating case preparation during training
- Perioperative medicine teams optimizing cardiac patient optimization before non-cardiac surgery
Best For
- Preoperative anesthetic planning for ejection fraction <35%, severe valvular disease, or combined pathology
- Drug interaction analysis when patients are on complex cardiac regimens
- High-risk case stratification and complications anticipation
- Induction strategy selection when standard approaches contraindicated
- Hemodynamic management protocol development for institutional cases







